Cowen sees hope for ECYT amid acquisition refocus; H.C.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) investors have a smile on their faces Monday morning, after the drug maker announced that the FDA is currently …
A glimpse into why Louise Chen believes Valeant is the better biotech play than Teva down the line.
Sophiris Bio Inc (NASDAQ:SPHS) provided an update on clinical trial enrollment of its Phase 2b study of topsalysin as a treatment for men …
Investors are racing to buy MannKind Corporation (NASDAQ:MNKD) shares following the news that the FDA has approved a labeling revision for the company’s diabetes …
